Wikidata entity: Q411781
C₁₈₁H₂₉₁N₅₅O₅₁S₂ (P274)

Quantities
| P4250 | defined daily dose | 20 |
| P2067 | mass | 4116.134297 |
| P3780 | active ingredient in | ... | Q29005879 (Forsteo) | Forsteo |
| P3780 | active ingredient in | ... | Q47521630 (Forteo) | Forteo |
| P373 | Commons category | String | Teriparatide | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P366 | has use | ... | Q679692 (biopharmaceutical) | biopharmaceutical |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284667 (LiverTox toxicity likelihood category E) | LiverTox toxicity likelihood category E |
| P2175 | medical condition treated | ... | Q68833 (bone fracture) | bone fracture |
| P2175 | medical condition treated | ... | Q165328 (osteoporosis) | osteoporosis |
| P2175 | medical condition treated | ... | Q1586088 (hypoparathyroidism) | hypoparathyroidism |
| P2175 | medical condition treated | ... | Q4941552 (bone disease) | bone disease |
| P2175 | medical condition treated | ... | Q55781316 (osteoarthritis susceptibility 1) | osteoarthritis susceptibility 1 |
| P2175 | medical condition treated | ... | Q55950294 (postmenopausal osteoporosis) | postmenopausal osteoporosis |
| P1748 | NCI Thesaurus ID | String | C61966 | ??? |
| P129 | physically interacts with | ... | Q7136149 (parathyroid hormone 2 receptor) | parathyroid hormone 2 receptor |
| P129 | physically interacts with | ... | Q21108487 (parathyroid hormone 1 receptor) | parathyroid hormone 1 receptor |
| P279 | subclass of | ... | Q14860476 (PTH) | PTH |
| P279 | subclass of | ... | Q104631433 (synthetic peptide) | synthetic peptide |
| P2868 | subject has role | ... | Q187661 (carcinogen) | carcinogen |
| P2868 | subject has role | ... | Q50430327 (bone density conservation agents) | bone density conservation agents |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | teriparatide | ??? |
| P267 | ATC code | H05AA02 |
| P7524 | CA PROP 65 ID | teriparatide |
| P231 | CAS Registry Number | 52232-67-4 |
| P683 | ChEBI ID | 135983 |
| P592 | ChEMBL ID | CHEMBL525610 |
| P661 | ChemSpider ID | 17289052 |
| P9272 | DeCS ID | 33002 |
| P11198 | DrugCentral ID | 4514 |
| P232 | EC number | 640-978-1 |
| P2566 | ECHA Substance Infocard ID | 100.168.733 |
| P646 | Freebase ID | /m/037n_c |
| P595 | Guide to Pharmacology Ligand ID | 4448 |
| P2062 | HSDB ID | 7367 |
| P235 | InChIKey | OGBMKVWORPGQRR-UMXFMPSGSA-N |
| P665 | KEGG ID | D06078 |
| P7830 | LiverTox ID | Teriparatide |
| P10245 | MedlinePlus drug identifier | a603018 |
| P486 | MeSH descriptor ID | D019379 |
| P672 | MeSH tree code | D06.472.699.590.850 |
| P672 | MeSH tree code | D12.644.548.587.850 |
| P6366 | Microsoft Academic ID (discontinued) | 2777308945 |
| P2115 | NDF-RT ID | N0000147632 |
| P10283 | OpenAlex ID | C2777308945 |
| P4235 | PatientsLikeMe treatment ID | teriparatide |
| P11199 | Probes And Drugs ID | PD071716 |
| P662 | PubChem CID | 16133850 |
| P662 | PubChem CID | 129631922 |
| P662 | PubChem CID | 132274287 |
| P662 | PubChem CID | 155817470 |
| P662 | PubChem CID | 16132393 |
| P662 | PubChem CID | 91933454 |
| P3417 | Quora topic ID | Teriparatide |
| P3417 | Quora topic ID | Teriparatide- |
| P3345 | RxNorm CUI | 32915 |
| P2877 | SureChEMBL ID | 29354459 |
| P2877 | SureChEMBL ID | 29357752 |
| P2877 | SureChEMBL ID | 29394193 |
| P4527 | UK Parliament thesaurus ID | 13244 |
| P2892 | UMLS CUI | C0070093 |
| P11143 | WikiProjectMed ID | Teriparatide |
| P3350 | World Health Organisation international non-proprietary name numeric ID | 5411 |
Why not click here or view trends?
log id: 1928193